Rescue of cardiomyopathy through U7snRNA‐mediated exon skipping in Mybpc3‐targeted knock‐in mice
Open Access
- 29 May 2013
- journal article
- research article
- Published by EMBO in EMBO Molecular Medicine
- Vol. 5 (7), 1128-1145
- https://doi.org/10.1002/emmm.201202168
Abstract
Exon skipping mediated by antisense oligoribonucleotides (AON) is a promising therapeutic approach for genetic disorders, but has not yet been evaluated for cardiac diseases. We investigated the feasibility and efficacy of viral‐mediated AON transfer in a Mybpc3‐targeted knock‐in (KI) mouse model of hypertrophic cardiomyopathy (HCM). KI mice carry a homozygous G>A transition in exon 6, which results in three different aberrant mRNAs. We identified an alternative variant (Var‐4) deleted of exons 5–6 in wild‐type and KI mice. To enhance its expression and suppress aberrant mRNAs we designed AON‐5 and AON‐6 that mask splicing enhancer motifs in exons 5 and 6. AONs were inserted into modified U7 small nuclear RNA and packaged in adeno‐associated virus (AAV‐U7‐AON‐5+6). Transduction of cardiac myocytes or systemic administration of AAV‐U7‐AON‐5+6 increased Var‐4 mRNA/protein levels and reduced aberrant mRNAs. Injection of newborn KI mice abolished cardiac dysfunction and prevented left ventricular hypertrophy. Although the therapeutic effect was transient and therefore requires optimization to be maintained over an extended period, this proof‐of‐concept study paves the way towards a causal therapy of HCM.This publication has 62 references indexed in Scilit:
- Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in miceJournal of Molecular and Cellular Cardiology, 2012
- Engineering Multiple U7snRNA Constructs to Induce Single and Multiexon-skipping for Duchenne Muscular DystrophyMolecular Therapy, 2012
- Long-term Restoration of Cardiac Dystrophin Expression in Golden Retriever Muscular Dystrophy Following rAAV6-mediated Exon SkippingMolecular Therapy, 2012
- AAV-based neonatal gene therapy for hemophilia A: long-term correction and avoidance of immune responses in miceGene Therapy, 2012
- The Status of Exon Skipping as a Therapeutic Approach to Duchenne Muscular DystrophyMolecular Therapy, 2011
- In vitro evaluation of novel antisense oligonucleotides is predictive of in vivo exon skipping activity for Duchenne muscular dystrophyThe Journal of Gene Medicine, 2010
- Characterization of a complex Duchenne muscular dystrophy-causing dystrophin gene inversion and restoration of the reading frame by induced exon skippingHuman Mutation, 2008
- Radial Displacement of Myosin Cross-bridges in Mouse Myocardium due to Ablation of Myosin Binding Protein-CJournal of Molecular Biology, 2007
- Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8Molecular Therapy, 2006
- Targeted Exon Skipping in Transgenic hDMD Mice: A Model for Direct Preclinical Screening of Human-Specific Antisense OligonucleotidesMolecular Therapy, 2004